Market Indices
Sector Heatmap
PMVP — PMV Pharmaceuticals, Inc
NasdaqPMV Pharmaceuticals, Inc
- O
- 1.59
- H
- 1.60
- L
- 1.48
- V
- 607.44K
PMVP — Latest News & Headlines
9 StoriesA Q1 2027 application for accelerated approval is planned for PMV’s ovarian cancer drug. - Stock Titan
A Q1 2027 application for accelerated approval is planned for PMV’s ovarian cancer drug. Stock Titan
Biotech Stocks At 52-Week Highs - KOD, MASS, OBIO, CDNA, PMVP - RTTNews
Biotech Stocks At 52-Week Highs - KOD, MASS, OBIO, CDNA, PMVP RTTNews
PMV Pharmaceuticals: Restoring Mutant P53 Could Create A Mispriced Cancer Opportunity - Seeking Alpha
PMV Pharmaceuticals: Restoring Mutant P53 Could Create A Mispriced Cancer Opportunity Seeking Alpha
Phase 2 single-drug enrollment is complete. PMV Pharma (PMVP) plans an ovarian cancer drug application. - Stock Titan
Phase 2 single-drug enrollment is complete. PMV Pharma (PMVP) plans an ovarian cancer drug application. Stock Titan
PMV Pharmaceuticals Director Matthew Joseph Eckler Granted 84,000 Stock Options - Kalkine Media
PMV Pharmaceuticals Director Matthew Joseph Eckler Granted 84,000 Stock Options Kalkine Media
PMV Pharmaceuticals stock adds Matt Eckler to its board opening the next clinical chapter - AD HOC NEWS
PMV Pharmaceuticals stock adds Matt Eckler to its board opening the next clinical chapter AD HOC NEWS
Show Me The Money: Kodiak Sciences Shares Deliver More Than 500% Return In Just Over A Year - RTTNews
Show Me The Money: Kodiak Sciences Shares Deliver More Than 500% Return In Just Over A Year RTTNews
Today's SEC Filings - Latest 10-K, 10-Q, 8-K Forms - Stock Titan
Today's SEC Filings - Latest 10-K, 10-Q, 8-K Forms Stock Titan
PMV Pharmaceuticals Adds Veteran Investor to Board - TipRanks
PMV Pharmaceuticals Adds Veteran Investor to Board TipRanks